China Sxt Pharmaceuticals (SXTC) on Tuesday filed a statement to register the resale of up to 157.5 million Class A ordinary shares by selling shareholder Smart Mart.
The shares may be issued under a July 3 securities purchase agreement that provides for up to $31.5 million in prepaid purchases.
The company said it will not receive any proceeds from the resale of shares by the selling shareholder.